SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-22-006737
Filing Date
2022-03-18
Accepted
2022-03-18 16:21:19
Documents
62
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K dffn20211231_10k.htm   iXBRL 10-K 1331235
2 EXHIBIT 10.7 ex_348717.htm EX-10.7 50564
3 EXHIBIT 10.8 ex_348718.htm EX-10.8 53431
4 EXHIBIT 21.1 ex_348719.htm EX-21.1 6431
5 EXHIBIT 23.1 ex_348951.htm EX-23.1 2373
6 EXHIBIT 31.1 ex_346478.htm EX-31.1 10384
7 EXHIBIT 31.2 ex_346479.htm EX-31.2 10358
8 EXHIBIT 32.1 ex_346480.htm EX-32.1 6326
14 a01.jpg GRAPHIC 3620
15 logo.jpg GRAPHIC 26138
16 tsc01.jpg GRAPHIC 29877
17 tsc02.jpg GRAPHIC 43157
18 tsc03.jpg GRAPHIC 29762
19 tsc04.jpg GRAPHIC 24027
20 tsc05.jpg GRAPHIC 22198
  Complete submission text file 0001437749-22-006737.txt   5108393

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA dffn-20211231.xsd EX-101.SCH 38395
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20211231_cal.xml EX-101.CAL 32637
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20211231_def.xml EX-101.DEF 252399
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20211231_lab.xml EX-101.LAB 254806
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20211231_pre.xml EX-101.PRE 276840
56 EXTRACTED XBRL INSTANCE DOCUMENT dffn20211231_10k_htm.xml XML 468996
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37942 | Film No.: 22752825
SIC: 2834 Pharmaceutical Preparations